ValiRx Announces Director Disclosure Update
Why we think this is neutral
This RNS announcement is a general director disclosure update and does not contain any of the mandatory news types required for a more detailed analysis. As a result, the sentiment is assessed as neutral.
Key Points
- ValiRx PLC issues director disclosure update
- Update relates to Martin Gouldstone, Chairman of ValiRx
- Oncimmune Holdings PLC, a company Gouldstone is a Director of, has announced intention to appoint administrators
Summary
The biopharmaceutical company ValiRx has issued a disclosure update regarding one of its directors.
ValiRx PLC, a life sciences company focusing on early-stage cancer therapeutics and women's health, has issued a disclosure update regarding Martin Gouldstone, the Chairman of the Company. The update states that Oncimmune Holdings PLC, a company which Martin Gouldstone is a Director of, has recently announced its intention to appoint administrators.
GENERAL UPDATE